Ridgetech Inc. announced a 2026 dual-engine growth strategy focused on integrating its pharmaceutical supply chain through its wholesale network, B2B platform and franchise system. The company plans to deepen cooperation with core suppliers, expand exclusive agency resources, and broaden distribution of higher-margin domestic and international brands and differentiated product lines. It also intends to strengthen compliance and financial risk controls, including full-process controls for agency products, improved rebate settlement, and an enhanced direct procurement model for branded products. Ridgetech’s online platform subsidiary Allright will serve as the digital growth engine, with goals to build a more efficient service network, expand its customer base to over 300,000, increase new B2B customers by 30% year over year, and raise online business penetration to more than 30%. The company also plans to expand coverage among independent pharmacies and clinics in Zhejiang Province and further develop value-added services. Ridgetech said it will integrate its offline wholesale unit Jiuxin Medicine with Allright by introducing Jiuxin supply chain products onto the platform, integrating procurement and sales processes, and using shared data to improve inventory planning, responsiveness and turnover efficiency, alongside joint recruitment activities supported by procurement advantages and digital tools.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ridgetech Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202603040830PR_NEWS_USPR_____CN99484) on March 04, 2026, and is solely responsible for the information contained therein.